MedTrace Logo

Promoting Engagement in the Drug Resistant TB/HIV Care Continuum in South Africa

NCT03162107 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 199

Last updated 2022-07-20

No results posted yet for this study

Summary

The goals of this research are to understand adherence and retention in care for multi-and extensively drug-resistant tuberculosis (M/XDR-TB) patients using a mixed methods approach.

Conditions

  • Patient Non-compliance

Sponsors & Collaborators

  • Columbia University

    collaborator OTHER

  • Centre for the AIDS Programme of Research in South Africa

    lead NETWORK

Principal Investigators

  • Nesri Padayatchi, MBChB · Centre for the AIDS Programme of Research in South Africa

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2020-01-10
Completion
2021-08-16

Countries

  • South Africa

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03162107 on ClinicalTrials.gov